Increasing evidence has suggested that AST/ALT is associated with an increased risk of cardiovascular diseases, DM, peripheral arterial disease, and nonalcoholic fatty liver disease. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.